Uncategorized
TOV ETF’s Rapid Rise: $100 Million Milestone Reached In Under Two Weeks
TOV ETF, designed to combat antisemitism and align with Jewish values, hits $100 million AUM in record time with strong investor interest. read more
‘I Lost Everything’—Trader Turns 0 Into $5 Million, Loses It All With Meme Coins That Were Supposed To Become The Next Dogecoin, Shiba Inu
An unlucky trader shared his story of turning nothing into $5 million over the course of the crypto bull run, only to lose it all again with meme coins. read more
Assessing Houlihan Lokey: Insights From 10 Financial Analysts
Latest Ratings for HLI Date Firm Action From To Mar 2022 Piper Sandler Maintains Neutral Mar 2022 Morgan Stanley Maintains Underweight Feb 2022 Morgan Stanley Maintains Underweight View More Analyst Ratings for HLI View the Latest Analyst Ratings read more
5 Analysts Assess MPLX: What You Need To Know
Latest Ratings for MPLX Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Jan 2022 Raymond James Maintains Outperform Jan 2022 B of A Securities Maintains Buy View More Analyst Ratings for MPLX View the Latest Analyst Ratings read more
What Analysts Are Saying About Enterprise Prods Partners Stock
Latest Ratings for EPD Date Firm Action From To Jan 2022 Mizuho Maintains Buy Jan 2022 Morgan Stanley Downgrades Overweight Equal-Weight Dec 2021 Wells Fargo Maintains Overweight View More Analyst Ratings for EPD View the Latest Analyst Ratings read more
Waldencast Q4 Earnings Preview: All Eyes On Tariff Impact, Obagi Skincare Brand
Waldencast is set to report Q4 earnings, with analysts projecting $81.69M sales. The company expands Obagi globally while mitigating potential tariff impacts. read more
3 China Stocks Soaring Over 50% YTD — While The S&P 500 Sinks
China’s stock market outperforms US as AI investments and shifting sentiment drive surge in tech stocks. Citi and Goldman Sachs revise ratings. read more